section name header

Pronunciation

si-METH-i-kone

Classifications

Therapeutic Classification: antiflatulent

Indications

REMS


Action

  • Causes the coalescence of gas bubbles.
  • Does not prevent the formation of gas.
Therapeutic effects:
  • Passage of gas through the GI tract by belching or passing flatus.

Pharmacokinetics

Absorption: No systemic absorption occurs.

Distribution: Not systemically distributed.

Metabolism/Excretion: Excreted unchanged in the feces.

Half-Life: Unknown.

Time/Action Profile

(antiflatulent effect)

ROUTEONSETPEAKDURATION
POimmediateunknown3 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

None significant.

Interactions

Drug-drug:

Route/Dosage

Availability

(Generic available)

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Degas, Extra Strength Gas-X, Flatulex, Gas-X, Genasyme, Maximum Strength Mylanta Gas, Mylanta Gas, Mylicon, Phazyme

Canadian Brand Names

Gas Relief, Infacol, Ovol, Pediacol